Inhibition of autoimmune diabetes by Fas ligand: The paradox is solved

Journal of Immunology

Volumn 164, Issue 6, 2000, Pages 2931-2936

  Kim, Sunshin ^a   Kim, Kyoung Ah ^a   Hwang, Dae Youn ^a   Lee, Tae H ^b   Kayagaki, Nobuhiko ^c   Yagita, Hideo ^c   Lee, Myung Shik ^a,d  

^a Sungkyunkwan University   (South Korea)

^b Yonsei University   (South Korea)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Samsung Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; FAS ANTIGEN; FAS LIGAND;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; GENE DELETION; GENETIC MANIPULATION; LYMPHOCYTE TRANSFER; MOUSE; NEWBORN; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034653419     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.6.2931     Document Type: Article

References (35)

1. Chervonsky, A. V., Y. Wang, F. S. Wong, I. Visintin, R. A. Flavell, C. A. Janeway, and L. A. Matis. 1997. The role of Fas in autoimmune diabetes. Cell 89:17.
2. Itoh, N., A. Imagawa, T. Hanafusa, M. Waguri, K. Yamamoto, H. Iwasashi, M. Moriwaki, H. Nakajima, M. Miyagawa, M. Namba, et al. 1997. Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 186:613.
3. Suarez-Pinxon, W., O. Sorensen, R. C. Bleachley, J. F. Elliott, R. V. Rejotte, and A. Rabinovitch. 1999. β-cell destruction in NOD mice correlates with Fas (CD95) expression on β-cells and proinflammatory cytokine expression in islets. Diabetes 48:21.
4. + T lymphocytes in transgenic nonobese diabetic mice. J. Clin. Invest. 103:1201.
5. Allison, J., and A. Strasser. 1998. Mechanisms of β cell death in diabetes: a minor role for CD95. Proc. Natl. Acad. Sci. USA 95:13818.
6. Kim, Y.-H., S. Kim, K.-A. Kim, H. Yagita, N. Kayagaki, K.-W. Kim, and M.-S. Lee. 1999. Apoptosis of pancreatic β-cells detected in accelerated diabetes of NOD mice: no role of Fas-Fas ligand interaction in autoimmune diabetes. Eur. J. Immunol. 29:455.
7. Pakala, S. V., M. Chivetta, C. B. Kelly, and I. D. Katz. 1999. In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor α. J. Exp. Med. 189:1053.
8. Wofsy, D., R. R. Hardy, and W. Seaman. 1984. The proliferating cells in autoimmune MRL/lpr mice lack L3T4, an antigen on "helper" T cells that is involved in the response to class II major histocompatibility antigens. J. Immunol. 132: 2686.
9. Adachi, M., R. Watanabe-Fukunaga, and S. Nagata. 1993. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. USA 90:1756.
10. d response gene. Nucleic Acids Res. 11:5055.
11. Wicker, L. A., B. J. Miller, and Y. Mullen. 1986. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes 35:855.
12. Theofilopoulos, A. N., R. S. Balderas, D. L. Shawler, S. Lee, and F. J. Dixon. 1981. Influence of thymic genotype on the systemic lupus erytthematosus-like disease and T cell proliferation on MRL/Mp-lpr/lpr mice. J. Exp. Med. 153:1405.
13. Kayagaki, N., N. Yamaguchi, F. Nagao, S. Matsuo, H. Maeda, K. Okumura, and H. Yagita. 1997. Polymorphism of murine Fas ligand that affects the biological activity. Proc. Natl. Acad. Sci. USA 94:3914.
14. Tanaka, M., T. Suda, T. Takahashi, and S. Nagata. 1995. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J. 14:1129.
15. + T cell-mediated cytotoxicity. J. Immunol. 152:1127.
16. Takahashi, T., M. Tanaka, J. Inazawa, T. Abe, T. Suda, and S. Nagata. 1994. Human Fas ligand: gene structure, chromosomal location and species specificity. Int. Immunol. 6:1567.
17. + T cells are important for the balance between protective and pathogenic cell-mediated immunity. J. Exp. Med. 179:589.
18. Davidson, W. F., F. J. Dumont, B. H. G., B. J. Fowlkes, and H. C. Morse. 1986. Phenotypic, functional, and molecular genetic comparisons of the abnormal lymphoid cells of C3H-lpr/lpr and C3H-gld/gld mice. J. Immunol. 136:4075.
19. Watanabe, D., T. Suda, H. Hashimoto, and S. Nagata. 1995. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J. 14:12.
20. Chu, J. L., P. Ramos, A. Rosendorff, J. Nikolic-Zugic, E. Lacy, A. Matsuzawa, and K. B. Elkon. 1995. Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regualtion and the graft-versus-host disease-like wasting syndrome. J. Exp. Med. 181:393.
21. Theofilopoulos, A. N., R. S. Balderas, Y. Gozes, M. T. Aguado, L. Hang, P. Morrow, and F. Dixon. 1985. Association of lpr gene with graft-vs-host disease-like syndrome. J. Exp. Med. 162:1.
22. Ogasawara, J., R. Watanabe-Fukunaga, M. Adachi, A. Matsuzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata. 1993. Lethal effect of the anti-Fas antibody in mice. Nature 364:806.
23. Tanaka, M., T. Suda, T. Yatomi, N. Nakamura, and S. Nagata. 1997. Lethal effect of recombinant human Fas ligand in mice pretreated with Propionibacterium acnes. J. Immunol. 158:2303.
24. Owen-Schaub, L. B., S. Yonehara, W. L. Cramp, and E. A. Grimm. 1992. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell. Immunol. 140:197.
25. Miyawaki, T., T. Uehara, R. Nibu, T. Tsuji, A. Yachie, S. Yonehara, and N. Taniguchi. 1992. Differential expression of apoptosis-related Fas antigen on lymphocytes subpopulations in human peripheral blood. J. Immunol. 149:3753.
26. Nishimura, Y., A. Ishii, Y. Kobayashi, Y. Yamasaki, and S. Yonehara. 1995. Expression and function of mouse Fas antigen on immature and mature T cells. J. Immunol. 154:4395.
27. Suda, T., M. Tanaka, K. Miwa, and S. Nagata. 1996. Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand. J. Immunol. 157:3918.
28. Salmon, M., D. Pilling, N. J. Borthwick, N. Viner, G. Janossy, P. A. Bacon, and A. N. Akbar. 1994. The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis. Eur. J. Immunol. 24:892.
29. Hattori, K., T. Hirano, H. Miyajima, N. Yamakawa, M. Tateno, K. Oshimi, N. Kayagaki, H. Yagita, and K. Okumura. 1998. Differential effects of anti-Fas ligand and anti-TNFα antibodies on acute graft-versus-host disease pathologies. Blood 91:4051.
30. Suda, T., H. Hashimoto, M. Tanaka, T. Ochi, and S. Nagata. 1997. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J. Exp. Med. 186:2045.
31. + cells collrelate with cytokine profiles in the spontaneously autoimmune diabetic mouse. Diabetes 45:71.
32. Michie, C. A., A. McLean, C. Alcock, and P. C. Beverley. 1992. Lifespan of human lymphocytes subsets defined by CD45 isoforms. Nature 360:264.
33. + T-cell memory, CD45R subsets and the persistence of antigen - a unifying concept. Immunol. Today 19: 60.
34. Tanaka, M., T. Suda, K. Haze, N. Nakamura, K. Sato, F. Kimura, K. Motoyoshi, M. Mizuki, S. Tagawa, S. Ohga, K. Hatake, A. H. Drummond, and S. Nagata. 1996. Fas ligand in human serum. Nat. Med. 2:317.
35. Zhang, H., Y. Yang, J. L. Horton, E. B. Samoilova, T. A. Judge, L. A. Turka, J. M. Wilson, and Y. Chen. 1997. Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer. J. Clin. Invest. 100:1951.